The Importance of Hemodynamic Monitoring in Cardiogenic Shock

Elazer Edelman, MD, PhD, discusses how achieving optimal therapeutic benefit in patients with cardiogenic shock requires metrics to guide titration and weaning of support. Dr. Edelman is a senior attending physician in the intensive care unit at Brigham and Women's Hospital, a professor at Harvard Medical School, and a professor and director of the Institute for Medical Engineering and Science at MIT. His publication "Dynamic Modulation of Device-Arterial Coupling to Determine Cardiac Output and Vascular Resistance" was featured in Annals of Biomedical Engineering in 2020.
According to Dr. Edleman's research, using the transvalvular positioning of a percutaneous ventricular assist device (pVAD), heart interactions are leveraged to determine cardiac output (CO) and systemic vascular resistance (SVR) near-continuously without disrupting therapeutic function.